SCHEMBL6414744

SCHEMBL6414744

COc1ccc(Nc2nc3nonc3nc2N/N=C/c2cccc([N+](=O)[O-])c2O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
HSP90AA1 P07900 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C19 P33261 2/20 0.46
TP53 P04637 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
ALOX15 P16050 1/20 0.46
NPC1 O15118 6/20 0.46
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
POLB P06746 3/20 0.46
MAPT P10636 8/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
GAA P10253 4/20 0.44
RAB9A P51151 4/20 0.44
PKM P14618 3/20 0.44
MAPK1 P28482 3/20 0.44
NFKB1 P19838 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6437966 1.00 ALDH1A1 (0.46) ALDH1A1HSP90AA1CYP1A2CYP3A4CYP2C19
SCHEMBL6413535 0.88 DDX3X (0.53) ALDH1A1HSP90AA1CYP1A2CYP3A4CYP2C19
SCHEMBL6438017 0.88 DDX3X (0.53) ALDH1A1HSP90AA1CYP1A2CYP3A4CYP2C19
SCHEMBL6418807 0.86 MAPT (0.55) ALDH1A1HSP90AA1CYP1A2CYP3A4CYP2C19
SCHEMBL6418810 0.86 MAPT (0.55) ALDH1A1HSP90AA1CYP1A2CYP3A4CYP2C19
SCHEMBL6439515 0.78 MAPT (0.51) ALDH1A1HSP90AA1CYP1A2CYP3A4CYP2C19
SCHEMBL6436226 0.78 MAPT (0.51) ALDH1A1HSP90AA1CYP1A2CYP3A4CYP2C19
SCHEMBL6419561 0.78 MAPT (0.53) ALDH1A1HSP90AA1CYP1A2CYP3A4CYP2C19
SCHEMBL6414748 0.77 IDO1 (0.43) ALDH1A1NPC1MEN1KMT2AMAPT
SCHEMBL6431543 0.75 DDX3X (0.49) ALDH1A1NPC1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143382-A1 Heterocyclic compounds as pharmaceutically active compounds 4SC AG (DE) 2005-06-30 US disclosed
WO-2005044270-A1 OXADIAZOLOPYRAZINE DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS 4SC AG (DE) 2005-05-19 WO disclosed
EP-1529531-A1 Oxadiazolopyrazine derivatives as pharmaceutically active compounds 4SC AG (DE) 2005-05-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143382-A1 Heterocyclic compounds as pharmaceutically active compounds NR5A2, NR1H2, NR2C2 ALDH1A1 1119/4885HSP90AA1 4673/4885CYP1A2 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.